These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 34052706)

  • 21. Update on Diagnosing and Reporting Malignant Pleural Mesothelioma.
    Savic I; Myers J
    Acta Med Acad; 2021 Apr; 50(1):197-208. PubMed ID: 34075773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep-learning based classification distinguishes sarcomatoid malignant mesotheliomas from benign spindle cell mesothelial proliferations.
    Naso JR; Levine AB; Farahani H; Chirieac LR; Dacic S; Wright JL; Lai C; Yang HM; Jones SJM; Bashashati A; Yip S; Churg A
    Mod Pathol; 2021 Nov; 34(11):2028-2035. PubMed ID: 34112957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.
    Rossi G; Davoli F; Poletti V; Cavazza A; Lococo F
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision Therapy for Mesothelioma: Feasibility and New Opportunities.
    Dulloo S; Bzura A; Fennell DA
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34067960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma.
    Anobile DP; Bironzo P; Picca F; Lingua MF; Morena D; Righi L; Napoli F; Papotti MG; Pittaro A; Di Nicolantonio F; Gigliotti C; Bussolino F; Comunanza V; Guerrera F; Sandri A; Leo F; Libener R; Aviles P; Novello S; Taulli R; Scagliotti GV; Riganti C
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical Diagnosis of Malignant Pleural Mesothelioma: 20 Years' Experience at a High-Volume Referral Center.
    Iaffaldano A; Charrier T; Lococo F; Damotte D; Bobbio A; Alifano M; Fournel L
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34064399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases.
    Tsim S; Alexander L; Kelly C; Shaw A; Hinsley S; Clark S; Evison M; Holme J; Cameron EJ; Sharma D; Wright A; Grundy S; Grieve D; Ionescu A; Breen DP; Paramasivam E; Psallidas I; Mukherjee D; Chetty M; Cox G; Hart-Thomas A; Naseer R; Edwards J; Daneshvar C; Panchal R; Munavvar M; Ostroff R; Alexander L; Hall H; Neilson M; Miller C; McCormick C; Thomson F; Chalmers AJ; Maskell NA; Blyth KG
    J Thorac Oncol; 2021 Oct; 16(10):1705-1717. PubMed ID: 34116230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma.
    Napoli F; Listì A; Zambelli V; Witel G; Bironzo P; Papotti M; Volante M; Scagliotti G; Righi L
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimated number of cancers attributable to occupational exposures in France in 2017: an update using a new method for improved estimates.
    Marant Micallef C; Charvat H; Houot MT; Vignat J; Straif K; Paul A; El Yamani M; Pilorget C; Soerjomataram I
    J Expo Sci Environ Epidemiol; 2023 Jan; 33(1):125-131. PubMed ID: 34172838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.
    Benzerdjeb N; Dartigues P; Kepenekian V; Valmary-Degano S; Mery E; Averous G; Chevallier A; Laverriere MH; Villa I; Sallé FG; Villeneuve L; Glehen O; Isaac S; Hommell-Fontaine J;
    Virchows Arch; 2021 Nov; 479(5):927-936. PubMed ID: 34169365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.
    Watanabe M; Higashi T; Ozeki K; Higashi AY; Sugimoto K; Mine H; Takagi H; Ozaki Y; Muto S; Okabe N; Matsumura Y; Hasegawa T; Shio Y; Suzuki H; Chiba H
    Sci Rep; 2021 Jun; 11(1):12554. PubMed ID: 34131154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant mesothelioma of tunica vaginalis: Two extremely rare case reports.
    Karabacakoğlu B; Kısa E; Özbilen MH; Karademir B; Yardım S; Çelik O; Süelözgen T; İlbey YÖ
    Urologia; 2023 May; 90(2):422-425. PubMed ID: 34105419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
    Lapidot M; Case AE; Weisberg EL; Meng C; Walker SR; Garg S; Ni W; Podar K; Hung YP; Carrasco RD; Knott A; Gokhale PC; Sharma S; Pozhitkov A; Kulkarni P; Frank DA; Salgia R; Griffin JD; Saladi SV; Bueno R; Sattler M
    Br J Cancer; 2021 Aug; 125(4):582-592. PubMed ID: 34088988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis.
    Vandenhoeck J; van Meerbeeck JP; Fransen E; Raskin J; Van Camp G; Op de Beeck K; Lamote K
    J Thorac Oncol; 2021 Sep; 16(9):1461-1478. PubMed ID: 34082107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment.
    Cugliari G; Allione A; Russo A; Catalano C; Casalone E; Guarrera S; Grosso F; Ferrante D; Sculco M; La Vecchia M; Pirazzini C; Libener R; Mirabelli D; Magnani C; Dianzani I; Matullo G
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study.
    Moretti G; Aretini P; Lessi F; Mazzanti CM; Ak G; Metintaş M; Lando C; Filiberti RA; Lucchi M; Bonotti A; Foddis R; Cristaudo A; Bottari A; Apollo A; Del Re M; Danesi R; Mutti L; Gemignani F; Landi S
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy.
    Magkouta SF; Vaitsi PC; Pappas AG; Iliopoulou M; Kosti CN; Psarra K; Kalomenidis IT
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of machine learning based on CT radiomics in the preoperative identification of peripheral nerve invasion in colorectal cancer: a two-center study.
    Liu NJ; Liu MS; Tian W; Zhai YN; Lv WL; Wang T; Guo SL
    Insights Imaging; 2024 Apr; 15(1):101. PubMed ID: 38578423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview on multimodal imaging for the diagnostic workup of pleural mesothelioma.
    Gabelloni M; Faggioni L; Brunese MC; Picone C; Fusco R; Aquaro GD; Cioni D; Neri E; Gandolfo N; Giovagnoni A; Granata V
    Jpn J Radiol; 2024 Jan; 42(1):16-27. PubMed ID: 37676382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomics under 2D regions, 3D regions, and peritumoral regions reveal tumor heterogeneity in non-small cell lung cancer: a multicenter study.
    Zhang X; Zhang G; Qiu X; Yin J; Tan W; Yin X; Yang H; Liao L; Wang H; Zhang Y
    Radiol Med; 2023 Sep; 128(9):1079-1092. PubMed ID: 37486526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.